These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1129504)

  • 21. Angular momentium, magnetic interactions, Jahn-Teller and environment effects in metalloporphyrin triplet states.
    Gouterman M
    Ann N Y Acad Sci; 1973; 206():70-83. PubMed ID: 4518414
    [No Abstract]   [Full Text] [Related]  

  • 22. Structure of water.
    Forslind E
    Q Rev Biophys; 1971 Nov; 4(4):325-63. PubMed ID: 4948245
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quantum pharmacology: state of scientific research].
    Chekman IS
    Lik Sprava; 2007; (8):3-11. PubMed ID: 18714459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular dichroism of drugs.
    Mitscher LA; Clark GW
    Lloydia; 1972 Dec; 35(4):311-43. PubMed ID: 4660510
    [No Abstract]   [Full Text] [Related]  

  • 25. [Progress and trends in the development of new drugs].
    Hüttenrauch R
    Pharmazie; 1978 Aug; 33(8):481-99. PubMed ID: 724776
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular determinants for drug-receptor interactions. 1. Solid-state structure and conformation of the novel nootropic agent 2-pyrrolidone-N-acetamide: X-ray and theoretical SCF-MO studies.
    Bandoli G; Clemente DA; Grassi A; Pappalardo GC
    Mol Pharmacol; 1981 Nov; 20(3):558-64. PubMed ID: 7329398
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantum dynamics of chemical reactions.
    Clary DC
    Science; 2008 Aug; 321(5890):789-91. PubMed ID: 18687951
    [No Abstract]   [Full Text] [Related]  

  • 28. Automated site-directed drug design: approaches to the formation of 3D molecular graphs.
    Lewis RA
    J Comput Aided Mol Des; 1990 Jun; 4(2):205-10. PubMed ID: 2213065
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of substituent constants in drug modification.
    Hansch C
    Farmaco Sci; 1968 Apr; 23(4):293-320. PubMed ID: 5680375
    [No Abstract]   [Full Text] [Related]  

  • 30. Structure--activity relationships of eseroline and morphine: ab initio quantum-chemical study of the electrostatic potential and of the interaction energy with water.
    Agresti A; Buffoni F; Kaufman JJ; Petrongolo C
    Mol Pharmacol; 1980 Nov; 18(3):461-7. PubMed ID: 7464812
    [No Abstract]   [Full Text] [Related]  

  • 31. THE HELICAL CONFORMATIONS OF POLYCYTIDYLIC ACID: STUDIES ON THE FORCES INVOLVED.
    FASMAN GD; LINDBLOW C; GROSSMAN L
    Biochemistry; 1964 Aug; 3():1015-21. PubMed ID: 14220659
    [No Abstract]   [Full Text] [Related]  

  • 32. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemical reaction kinetics and its role in the study of drug stability].
    Seydel JK
    Arzneimittelforschung; 1967 Jul; 17(7):791-5. PubMed ID: 5632833
    [No Abstract]   [Full Text] [Related]  

  • 34. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular orbital studies of the metabolism of fluroxene and analogous fluorinated ether anesthetics.
    Adams SM; Murphy MJ; Kaminsky LS
    Mol Pharmacol; 1981 Sep; 20(2):423-8. PubMed ID: 6117788
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of multivariate statistics in industrial pharmacology.
    Lewi PJ
    Pharmacol Ther B; 1978; 3(4):481-537. PubMed ID: 366629
    [No Abstract]   [Full Text] [Related]  

  • 37. Conformational energies and geometries of narcotics, using a potential function method.
    Froimowitz M
    NIDA Res Monogr; 1978; (22):359-73. PubMed ID: 30910
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electrical dipolar momentum and molecular structure, with observations on their relation to pharmaceutical chemistry].
    KOFOD H
    Dan Tidsskr Farm; 1951 Sep; 25(9):298-318. PubMed ID: 14879533
    [No Abstract]   [Full Text] [Related]  

  • 39. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.
    Martin YC
    J Med Chem; 1981 Mar; 24(3):229-37. PubMed ID: 7265109
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipophilic character and biological activity of drugs. II. The parabolic case.
    Hansch C; Clayton JM
    J Pharm Sci; 1973 Jan; 62(1):1-21. PubMed ID: 4566530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.